Fomepizole (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Fomepizole drug offered from Mylan Institutional LLC. This Antidote [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Fomepizole
SUBSTANCE NAME: FOMEPIZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antidote [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-10-09
END MARKETING DATE: 0000-00-00


Fomepizole HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFomepizole from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/mL)
START MARKETING DATE: 2012-10-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-211_be2c337b-ea12-46e4-82e0-fb3e3620b7ca
PRODUCT NDC: 67457-211
APPLICATION NUMBER: ANDA078639

Other FOMEPIZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional LLCFomepizole
PALADIN LABORATORIES (USA) INCAntizol
Sandoz Inc.fomepizole
X-GEN Pharmaceuticalsfomepizole